Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Satish Bhawsar"'
Autor:
Satish Bhawsar, Shivaji Pawar, Prasad Deshpande, Ravindra Yeole, Rajesh Chavan, Manohar Nandanwar, Sachin Bhagwat, Mahesh Patel
Publikováno v:
Bioorganicmedicinal chemistry letters. 71
Increased resistance to gram positive infections have highlighted the limitations of currently available drug treatments including penicillins, macrolides and glycopeptides. As an alternative to address these challenges; Linezolid, the first antibiot
Autor:
Satish Bhawsar, Sanjeev Joshi, Prasad Deshpande, Ravindra Yeole, Sachin Bhagwat, Mahesh Patel
Publikováno v:
Bioorganicmedicinal chemistry letters. 63
Novel antibacterial agents needed constantly to counter the ever emergent resistance development to commercially available drugs; one of the effective synthetic antibacterial classes is fluoroquinolone (FQ). This study includes structure activity rel
Autor:
Satish Bhawsar, Mahesh Patel, Rajesh P. Kale, Sachin Bhagwat, Prasad K Deshpande, Ravindra D. Yeole
Publikováno v:
Bioorganicmedicinal chemistry letters. 54
Levonadifloxacin is a parenteral anti-MRSA benzoquinolizine antibacterial drug recently launched as, EMROK in India to treat acute bacterial skin and skin structure infections (ABSSSI) in hospitalized patients. As a step down therapy an oral form of
Autor:
Michael R. Jacobs, Mahesh Vithalbhai Patel, David C. Hooper, Vijaya N Desai, Ravindra D. Yeole, Shrikant V Gupte, Milind C Shukla, Rasendrakumar Jha, Nitin Shetty, Satish Bhawsar, Peter C. Appelbaum, Bülent Bozdogan, Prasad K Deshpande, Noel J. De Souza, Jacob Strahilevitz, Habil F. Khorakiwala
Publikováno v:
Journal of medicinal chemistry. 48(16)
There is an urgent medical need for novel antibacterial agents to treat hospital infections, specially those caused by multidrug-resistant Gram-positive pathogens. The need may also be fulfilled by either exploring antibacterial agents having new mec